2m 2m 2m 2m 2m 2m 2m
RHYTHM PHARM (RYTM)
NASDAQ
$106.31+$4.92 (+4.85%)
Price as of Jun 23, 2026 5:03 PM EDT- $7.0BMarket Cap
- 63.19%1-Year Change
- BiotechnologyIndustry
RHYTHM PHARM (RYTM)
$106.31+$4.92 (+4.85%)
RYTM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $101.39 | ||
Change | +$4.60 (+4.75%) | ||
Open | $97.80 | ||
High | $102.14 | ||
Low | $97.44 | ||
Previous Close | $96.79 | ||
Volume | 1,319,798 | ||
30-Day Average Volume | 793,704 | ||
1-Week Change | 13.03% | ||
1-Month Change | 15.43% | ||
1-Year Change | 63.19% | ||
3-Year Change | 438.74% | ||
5-Year Change | 393.14% | ||
Fundamentals | |||
Shares Outstanding | 68.6M | ||
Total Assets | $442.3M | ||
Market Cap | $7.0B | ||
Enterprise Value | $7.0B | ||
Period: QTR TTM FY | |||
Revenue | $60.1M | ||
Net Income | -$55.6M | ||
Free Cash Flow | -$44.2M | ||
EBIT | -$55.1M | ||
EBITDA | -$54.9M | ||
Net Working Capital | $326.9M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -128 | ||
Enterprise Value/Revenue | 116 | ||
P/B | 57 | ||
P/E | -122 | ||
PEG | 7 | ||
Price/Free Cash Flow | -157 | ||
Price/Operating Cash Flow | -157 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue